SOX9 as a Potential Biomarker of Good Prognosis in Stage II Colon Cancer

被引：0
|
作者：
Archilla, Ivan [1 ]
Cuatrecasas, Miriam [1 ]
Lahoz, Sara [2 ]
Parra, Carolina [2 ]
Mas, Alba [2 ]
Camps, Jordi [2 ]
机构：
[1] Univ Barcelona, Hosp Clin, Barcelona, Spain
[2] Univ Barcelona, Hosp Clin, IDIBAPS, Barcelona, Spain
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
542
引用
收藏
页码：S525 / S525
页数：1
相关论文
共 50 条
  • [1] SOX9 mutation correlates with good prognosis and immune infiltration in stage II colon cancer
    Archilla, I.
    Cuatrecasas, M.
    Lahoz, S.
    Parra, C.
    Mas, A.
    Camps, J.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S20 - S20
  • [2] SOX9 expression predicts relapse of stage II colon cancer patients
    Espersen, Maiken Lise Marcker
    Linnemann, Dorte
    Christensen, Ib Jarle
    Alamili, Mahdi
    Troelsen, Jesper T.
    Hogdall, Estrid
    HUMAN PATHOLOGY, 2016, 52 : 38 - 46
  • [3] Prognostic impact of SOX9 in stage II colon cancer: Results from a large nationwide cohort
    Hansen, Torben
    Trabjerg, Natacha D.
    Kjaer-Frifeldt, Sanne
    Eriksen, Ann Christina
    Lindebjerg, Jan
    Jensen, Lars Henrik
    Jakobsen, Anders Kristian Moeller
    Sorensen, Flemming Brandt
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [4] The local and circulating SOX9 as a potential biomarker for the diagnosis of primary bone cancer
    Hosseini, Ameinh
    Mirzaei, Alireza
    Salimi, Vahid
    Jamshidi, Khodamorad
    Babaheidarian, Pegah
    Fallah, Soudabeh
    Rampisheh, Zahra
    Khademian, Narges
    Abdolvahabi, Zohreh
    Bahrabadi, Mehrdad
    Ibrahimi, Mostafa
    Hosami, Fatemeh
    Tavakoli-Yaraki, Masoumeh
    JOURNAL OF BONE ONCOLOGY, 2020, 23
  • [5] Prognostic impact of SOX9 in stage II colon cancer: Results from a large nationwide cohort.
    Hansen, Torben
    Kjaer-Frifeldt, Sanne
    Eriksen, Ann Christina
    Lindebjerg, Jan
    Jensen, Lars Henrik
    Jakobsen, Anders Kristian Moeller
    Sorensen, Flemming Brandt
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Association between SOX9 expression in Mexican patients with early colon cancer stage
    Ruiz-Garcia, Erika
    Galicia, Tatiana
    Fernandez Figueroa, Edith
    Lino-Silva, Saul
    Lopez-Camarillo, Cesar
    Marchat, Laurence
    Calderillo, German
    Zinser, Juan
    Meneses-Garcia, Abelardo
    Astudillo-de la Vega, Horacio
    CANCER RESEARCH, 2018, 78 (13)
  • [7] SOX9 is associated with advanced T-stages of clinical stage II colon cancer in young Mexican patients
    Lizarraga-Verdugo, Erik
    Carmona, Tatiana Galicia
    Ramos-Payan, Rosalio
    Avendano-Felix, Mariana
    Bermudez, Mercedes
    Parra-Niebla, Maryelv
    Lopez-Camarillo, Cesar
    Fernandez-Figueroa, Edith
    Lino-Silva, Leonardo
    Saavedra, Herminia Arvelo
    Vela-Sarmiento, Itzel
    Ovando, Roberto Cardenas
    Ruiz-Garcia, Erika
    Aguilar-Medina, Maribel
    ONCOLOGY LETTERS, 2021, 22 (01)
  • [8] SOX9 modulates cancer biomarker and cilia genes in pancreatic cancer
    Edelman, Hannah E.
    McClymont, Sarah A.
    Tucker, Tori R.
    Pineda, Santiago
    Beer, Rebecca L.
    McCallion, Andrew S.
    Parsons, Michael J.
    HUMAN MOLECULAR GENETICS, 2021, 30 (06) : 485 - 499
  • [9] A Short SOX9 Peptide Mimics SOX9 Tumor Suppressor Activity and Is Sufficient to Inhibit Colon Cancer Cell Growth
    Blache, Philippe
    Canterel-Thouennon, Lucile
    Busson, Muriel
    Verdie, Pascal
    Subra, Gilles
    Ychou, Marc
    Prevostel, Corinne
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (08) : 1386 - 1395
  • [10] Sox9: A potential regulator of cancer stem cells in osteosarcoma
    Li, Xiucheng
    Lv, Zuo
    Zhou, Ping
    Zhang, SongOu
    Jiang, Chao
    OPEN MEDICINE, 2024, 19 (01):
12345